• 主题
高级搜索  >
历史搜索 清空历史
首页> 中文期刊> 《TMR药物联合治疗》 >Curcumin suppresses proliferation of MCF-7 breast cancer cells by modulating gap junction signaling

Curcumin suppresses proliferation of MCF-7 breast cancer cells by modulating gap junction signaling

         
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

cqvip:Curcumin, an agent isolated from turmeric, shows therapeutic potential against breast cancer. However, the mechanism underlying anticancer activity has not been fully expounded. In this research, bioinformatics was utilized to analyze molecular mechanism of curcumin and the results have been proved in breast cancer cells subsequently. In order to generate a breast cancer molecular network with which curcumin interacts, target proteins of curcumin from PubChem were combined with genes implicated in breast cancer in the NCBI within Ingenuity Pathway Analysis software. Predicted curcumin targets were verified by reverse transcription-quantitative polymerase chain reaction. Bioinformatics identified gap junction signaling and 14-3-3-mediated adherens junctions as the main canonical signaling pathways targeted by curcumin. Moreover, curcumin can substantially up-regulates the gap junction protein connexin in breast cancer cells. Our results suggest that curcumin through modulation of the gap junction signaling pathway to inhibit cell proliferation and differentiation in breast cancer cells.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号